Leuk Lymphoma 2014 Oct 20:1-6

The current situation and future aspects of the cost-effectiveness in chronic myeloid leukemia treatment.

Eskazan AE, Soysal T.
Chronic myeloid leukemia; cost-effectiveness; generic; imatinib; tyrosine kinase inhibitor
ukemia; cost-effectiveness; generic; imatinib; tyrosine kinase inhibitor